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ORIGINAL ARTICLE
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ABSTRACT
The aim of this study was to analyze differences in chromosomal aberrations and euploidy in embryos of
each translocation type and gender of carrier in the case series of 10 couples with balanced transloca-
tions who underwent IVF with embryos trophectoderm (TE) biopsy and PGT-A to detect chromosomal
aberrations. This is a Case Series (Retrospective study). In each case, controlled ovarian hyperstimulation,
oocyte insemination with intracytoplasmic sperm injection (ICSI) and cultivation gave multiple blastocysts,
that underwent trophectoderm (TE) biopsy with PGT-A analysis using aCGH and NGS. Number of total
unbalanced translocations compared to the number of sporadic aneuploid embryos was 39.6% to 39.6%
(50% to 50% of all 37 aneuploid embryos). The highest euploidy rate was in male carrier group – 26.7%
and the lowest in the Robertsonian translocation carrier group – 18.2%. Sporadic aneuploidy – 68.2% was
highest in Robertsonian translocation carrier group and lowest in female group – 11.1%. Chromosomal
aberrations related to translocation were highest in female carrier group – 77.8% and lowest in
Robertsonian translocation carrier group – 13.6%. Our study showed that expectancy of total embryo
aneuploidy rates will be higher in carriers, than in people with normal karyotype. The prevalence of
chromosomal aberrations related to translocation was 4.5 times higher in Reciprocal carrier group than in
Robertsonian translocation carrier group. Among maternal and paternal carrier groups, the embryos from
female carriers had the lowest euploidy rate, unbalanced translocation rate 4.7 times higher than in the








From population-based congenital anomaly registers in Europe
more than 10,000 cases with a chromosomal abnormality are
described, giving a total birth prevalence rate of 43.8/10,000 births
[1]. This accounts for 15% of the major congenital anomalies
diagnosed before the age of 1 year in Europe, and are associated
with 25% of perinatal deaths [2]. It is known that patients with
recurrent pregnancy loss, previous IVF failures, and prior aneu-
ploid pregnancies have a significantly higher and age-independent
aneuploidy rate compared to patients without infertility [3].
Abnormal karyotype in one of the parents is a serious additional
problem on the way to a successful pregnancy. As described by S.
Munne [4] among 1284 couples with recurrent miscarriage, 58
(4.5%) are carriers of translocations. In the next pregnancy cou-
ples carrying reciprocal translocations (n¼ 47) miscarries signifi-
cantly more often (68%), compared to only 28% for couples
without structural chromosomal abnormalities [4].
Together with development of molecular genetics IVF clinics
use Preimplantation Genetic Testing for aneuploidies (PGT-A)
to test embryos and select for transferring those without
chromosomal abnormalities [5].
In the past, for an attempt to detect balanced and unbalanced
chromosomal translocations, translocation breakpoint-specific
and closely flanking fluorescence in situ hybridization (FISH)
probes have been used to detect both structural and numerical
aberrations in either interphase cells or in polar bodies [6,7].
Now abnormalities in embryos are measured with the new
generation of methods, including comparative genomic hybrid-
ization (CGH), microarrays (aCGH and single nucleotide poly-
morphism arrays), quantitative polymerase chain reaction, and
next-generation sequencing (NGS). These methodologies allow
comprehensive chromosomal analysis, provide high accuracy,
and have yielded encouraging preliminary clinical data [8].
Studies show, that the ongoing pregnancy rate per initiated cycle
after array comparative genomic hybridization is significantly
higher than after fluorescent in-situ hybridization in all trans-
location carriers (36.4% vs 9.0%; p¼ .010) [9].
Balanced rearrangements represent one of the most common
forms of genetic abnormality affecting 1 in every 500 (0.2%)
individuals. Difficulties processing the abnormal chromosomes
during meiosis lead to an elevated risk of chromosomally abnor-
mal gametes, resulting in high rates of miscarriage and/or chil-
dren with congenital abnormalities [10].
These rearrangements in embryos may occur as a de novo
event or can be the product of abnormal karyotype of one of the
parents. Carriers of balanced translocations are most often iden-
tified by karyotyping or by genetic analysis of products of con-
ception after embryonic demise with subsequent karyotyping of
parents [11]. Two types of balanced structural chromosomal
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rearrangements are known – Robertsonian translocations and
reciprocal translocations.
Robertsonian translocations (ROBs) are chromosomal rear-
rangements that result from the fusion of the entire long arms of
two acrocentric chromosomes. Robertsonian translocations are
one of the most frequent reorganizations in humans. Most of the
cases analyzed correspond to rearrangements with chromosomes
from the D-group (chromosomes 13, 14 and 15), whereas some
rare Robertsonian translocations are scarcely found in the litera-
ture, mainly those with both chromosomes from the G-group
(chromosomes 21 and 22) and those involving chromosomes
from both groups (D;G translocations) [10,12,13].
Reciprocal translocation is a type of chromosome rearrange-
ment that is involved in the exchange of chromosome segments




From the 36 patients with changes in karyotypes that were found
in IVF Riga clinic from period 2013–2018 10 patients undergoing
IVF with TE biopsy for PGT-A and who signed informed consent
were eligible for the study. Three patients were with the most fre-
quent type of Robertsonian translocation from the D group
(between 13 and 14 chromosomes) and seven patients with vari-
ous reciprocal translocations. One hundred and eighty oocytes
were collected, 140 fertilized normally, 90 embryos were frozen,
69 were biopsied, and 48 from those were analyzed with PGT-A.
Parental karyotype
Parental karyotyping was performed using classical G band cyto-
genetic approach. Peripheral blood cells (lymphocytes) were cul-
tivated for 72 h in the PB-MAXTM Karyotyping Medium. The
colcemide solution was added and put to a thermostat to stop
the cell division. Fixative, consisting of methanol and acetic acid,
was added to each sample of cells. Processed cells in their meta-
phase state were fixated on the glass slide with chromosome
staining using Giemsa stain. At least 15 metaphases analyzed for
each patient with a microscope using Lucia Kario software pro-
gram. Karyotype was analyzed based on the International System
for Human Cytogenomic Nomenclature (ISCN 2016) criteria.
Ovarian stimulation, insemination, and embryo biopsy
Controlled ovarian stimulation was performed using recombin-
ant follicle-stimulating hormone (Follitropin Alfa) and gonado-
tropin-releasing hormone antagonist (Ganirelix acetate injection
or Cetrorelix acetate). All the dosages were used considering
ovarian reserve and anti-mullerian hormone values in patients
medical histories. When the lead follicle reached its mean diam-
eter 18–20mm, 6500 IU human chorionic gonadotropin agonist
(hCG) were injected subcutaneously for ovulation induction.
Oocyte retrieval was performed 35–36 h after hCG injection, and
all metaphase II oocytes underwent intracytoplasmic sperm injec-
tion (ICSI). Before the procedure, the quality of sperm of 7 out
of 10 men were analyzed with main semen analysis test, semen
functional test, and semen fragmentation test.
Embryos were grown in Life Global cultivation media. On
day five when embryos have reached the blastocyst stage, assisted







































































































































































































































































































































































































































































































































































20 V. FODINA ET AL.
in the zona pellucida for trophectoderm (TE) biopsy. Five to ten
TE cells were aspirated with a biopsy pipette and the specimens
were cleaved. Embryo vitrification was performed using Kitazato
vitrification cryotop method.
Comprehensive chromosomal screening
Whole genome amplification from TE cells was done using
SurePlex reagent kit, electrophoresis was done to confirm suc-
cessful DNA amplification and exclude amplification in negative
amplification controls. PGT-A was done using aCGH Illumina
24Sure arrays or using NGS – Illumina VeriSeq PGS kit. For
analysis BlueFuse software was used for both approaches.
Statistical analysis with statistical significance level was not
done due to small patient group.
Results
A total of 180 oocytes were collected, 140 (77.8%) fertilized nor-
mally, resulting in 90 (64%) embryos that reached the matur-
ation stage on day 5. A biopsy was performed to 69 blastocysts
and PGT-A was done for biopsies from 48 embryos (Table 1).
Total abnormality rate from the 48 embryos were 79.2% (10 –
euploid, 38 – with chromosomal structural aberrations or aneu-
ploidies) (Table 2). Number of total unbalanced translocations
compared to the number of sporadic aneuploid embryos was
39.6% to 39.6% (50% to 50% of all 37 abnormal embryos).
In 22 embryos, that were analyzed from the carriers of
Robertsonian translocations the rate of unbalanced translocations
was 81.8%, whereas from the Reciprocal translocation carrier
group the unbalanced translocation rate in embryos was 76.9%.
In 18 embryos from 5 couples where female was a carrier of
balanced translocation, with the mean age of 33.6 (ranged from
31 to 36 years), and 30 embryos from 5 couples where male was
a carrier of balanced translocation, with the mean age of 39
(ranged from 28 to 46 years), the percentage of unbalanced trans-
location rate in embryos resulting from woman compared to
men were 88.9% and 73.3%.
The highest euploidy rate was in male carrier group – 26.7%
and the lowest in the Robertsonian translocation carrier group –
18.2%. Sporadic aneuploidy of 68.2% was highest in
Robertsonian translocation carrier group and lowest in female
carrier group – 11.1%. Unbalanced translocation rate in embryos
was highest in female carrier group – 77.8% and lowest in
Robertsonian group – 13.6%.
One female patient with a reciprocal translocation between 13
and 20 chromosomes had unbalanced chromosomal transloca-
tions inherited from mother in all six tested embryos. One male
patient with type D Robertsonian translocation between 13 and
14 chromosomes had aneuploidy in 12 embryos from 16 tested
and only one of them had aneuploidy associated with abnor-
mal karyotype.
After PGT-A results were obtained, 5 of 10 female patients
needed new stimulation as PGT-A showed 0 euploid embryos. In
1 female patient with reciprocal translocation, pregnancy did not
occur after FET. 1 patient, whose husband was carrier of recipro-
cal translocation, naturally got pregnant. Two patients got preg-
nant after IVF with husbands being Robertsonian and reciprocal
translocation carriers. One child was born from woman-recipro-
cal translocation carrier (Table 3).
Discussion
We have shown that additional whole chromosome aneuploidies
detected by aCGH and NGS diagnosis on embryonic material
from translocation carrier parents persist and are widespread in
79.2% of embryos. The 4 different publications had described the
rate of abnormal embryos in their study. Mean percentage of
chromosomal aberrations between four of them were 79.5%,
(69.4% [15], 85.5% [16], 84% [17], 79% [18]), which makes it
fairly close to our findings. In the comparison between the bal-
anced translocation type, the difference in unbalanced chromo-
somal translocations in embryos between Robertsonian and
Reciprocal translocation carriers are not that high – 81,8% to
76,9%, with a slight prevalence from the carriers of Robertsonian
translocations. There are conflicting data about this aspect. For
example in one study on 432 PGD of translocation cycles per-
formed by ‘Reprogenetics’, indicated that on average 72% of
embryos from Robertsonian translocation cycles and 82% of
reciprocal translocation cycles are abnormal [4]. In the other art-
icle, patients with Robertsonian translocations produced a larger
number of normal/balanced embryos than those with reciprocal
translocations, 76% versus 33% [19].
If we look at the sporadic and unbalanced chromosomal aber-
ration rates in embryos between Robertsonian and reciprocal
translocation carriers we can see that prevalence of sporadic
abnormality events is almost 5 times higher than unbalanced
translocations in embryos in the Robertsonian translocation car-
rier group. Where the results in reciprocal translocation carrier
group are opposite – unbalanced translocation rates are 4 times
higher than sporadic aneuploidies. In one of the studies, the
sporadic aneuploidy rates that were related to Robertsonian
translocation was 31%, wherein reciprocal translocations was 6%
[20]. More sporadic events in Robertsonian translocations car-
riers than in reciprocal translocation carriers were shown in the
article of 122 informative sibships, where numbers were 74% and
25% [21]. This could lead to suggestion that despite the preva-
lence in abnormality from Robertsonian translocation carriers, in
this group it is less likely to get translocation – related abnormal-
ity, thus increasing the probability of getting pregnant. There
have been few studies that proved this statement. The incidence
of spontaneous abortion is nearly 50% in balanced reciprocal
translocation carriers and between 20 and 25% in carriers of bal-
anced Robertsonian translocation families [22]. From the total
number of 629 embryos, 21.9% were detected as normal or with
balanced translocation – 25.2% in couples with balanced
Robertsonian translocation and 16.4% with balanced reciprocal
translocation. Embryo transfer was performed in 30 cycles












Total 48 39.6% 39.6% 79.2% 20.8%
Robertsonian translocation 22 13.6% 68.2% 81.8% 18.2%
Reciprocal translocation 26 61.5% 15.4% 76.9% 23.1%
Maternal 18 77.8% 11.1% 88.9% 11.1%
































































































































































































































































































































































































































































































































































































































































































22 V. FODINA ET AL.
(68.2%) in couples with balanced Robertsonian translocation and
27 (54%) in couples with balanced reciprocal translocations [23].
Among the balanced reciprocal translocation group, the live
delivery rate was 8.3% per ovum pick-up cycle and 18.2% per
embryo transfer cycle and among the balanced Robertsonian
translocation group, the live delivery rate was 14.3% per ovum
pick-up cycle and 20.0% per embryo transfer cycle [24]. The per-
centage of embryos consistent with normal or balanced segrega-
tion (55.1% vs. 27.1%) and clinical pregnancy (62.5% vs. 19.2%)
rates were higher in Robertsonian than the reciprocal transloca-
tion from male carriers [25]. A difference between carriers of
reciprocal and Robertsonian translocations in terms of the pro-
portion of abnormal embryos and structurally normal chromo-
somes was 63.3% vs. 27.5%, and 1.1% vs. 0.3%, respectively [26].
Between male and female carriers, it seems that not only total
aneuploidy rates are higher in the maternal group, but the per-
centage of embryos related to translocation is 4.7 times higher
than in the paternal group, even after taking into account mater-
nal age. This also could lead to a thought, that if a mother is a
carrier of translocation, the percentage of miscarriages and
abnormalities in fetuses will be more frequent than from male
carriers. Statistically significant difference in the rate of embryos
with unbalanced translocations between male and female trans-
location carriers (12% vs. 24%; p< .5) has been described [27].
Studies, where patients with balanced translocations in all
possible aspects are compared are not that many and we need to
gain more proof for the purpose of more effective consultation
and evaluation of patients with balanced chromosomal changes
and prognostic accuracy of embryos that are aneuploid.
Our study showed that expectancy of total embryo aneuploidy
rates will be higher in carriers, than in people with normal
karyotype. The prevalence of aneuploidy related to translocation
is 4.5 times higher in balanced reciprocal translocation carrier
group, than in balanced Robertsonian translocation carrier
group. Among maternal carrier and paternal carrier groups, the
embryos from female carriers have the lowest euploidy rate; have
unbalanced translocation rate 4.7 times higher than in the male
group and higher total aneuploidy rates.
Compliance with an ethical standard
The study follows principles of the Declaration of Helsinki.
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